Calcitonin, amylin, CGRP and adrenomedullin

[1]  A. W. Shaw,et al.  Pharmacological Characterization of MK-0974 [N-[(3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of , 2008, Journal of Pharmacology and Experimental Therapeutics.

[2]  P. Sexton,et al.  Determinants of 1-Piperidinecarboxamide, N-[2-[[5-Amino-l-[[4-(4-pyridinyl)-l-piperazinyl]carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxyphenyl)methyl]-2-oxoethyl]-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl) (BIBN4096BS) Affinity for Calcitonin Gene-Related Peptide and Amylin Receptors—The Role of Rec , 2006, Molecular Pharmacology.

[3]  P. Sexton,et al.  Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes , 2005, Molecular Pharmacology.

[4]  S. Brain,et al.  Vascular actions of calcitonin gene-related peptide and adrenomedullin. , 2004, Physiological reviews.

[5]  R. Lipton,et al.  CGRP antagonists in the acute treatment of migraine , 2004, The Lancet Neurology.

[6]  C. Klein,et al.  Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes* , 2004, Journal of Biological Chemistry.

[7]  Y. Takei,et al.  Identification of a novel adrenomedullin gene family in teleost fish. , 2003, Biochemical and biophysical research communications.

[8]  D. Smith,et al.  CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22–52, CGRP8–37 and BIBN4096BS , 2003, British journal of pharmacology.

[9]  N. Minamino,et al.  Calcitonin Receptor-stimulating Peptide, a New Member of the Calcitonin Gene-related Peptide Family , 2003, The Journal of Biological Chemistry.

[10]  D. Hay,et al.  CGRP receptor heterogeneity: a role for receptor component protein? , 2003, Trends in Endocrinology & Metabolism.

[11]  Patrick M. Sexton,et al.  International Union of Pharmacology. XXXII. The Mammalian Calcitonin Gene-Related Peptides, Adrenomedullin, Amylin, and Calcitonin Receptors , 2002, Pharmacological Reviews.

[12]  M. Rees,et al.  Adrenomedullin and the microvasculature. , 2002, Trends in pharmacological sciences.

[13]  R. Quirion,et al.  The molecular pharmacology of CGRP and related peptide receptor subtypes. , 2000, Trends in pharmacological sciences.

[14]  M. Rosenblatt,et al.  CGRP-RCP, a Novel Protein Required for Signal Transduction at Calcitonin Gene-related Peptide and Adrenomedullin Receptors* , 2000, The Journal of Biological Chemistry.

[15]  P. Sexton,et al.  Amylin receptor phenotypes derived from human calcitonin receptor/RAMP coexpression exhibit pharmacological differences dependent on receptor isoform and host cell environment. , 2000, The Journal of pharmacology and experimental therapeutics.

[16]  K. Rudolf,et al.  Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist , 2000, British journal of pharmacology.

[17]  M Morfis,et al.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. , 1999, Molecular pharmacology.

[18]  S. Foord,et al.  The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. , 1999, Molecular pharmacology.

[19]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[20]  N. Aiyar,et al.  A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor (*) , 1996, The Journal of Biological Chemistry.

[21]  P. Sexton,et al.  Isoforms of the rat calcitonin receptor: consequences for ligand binding and signal transduction. , 1994, Endocrinology.

[22]  P. Sexton,et al.  Molecular pharmacology of the calcitonin receptor. , 2002, Receptors & channels.